Envestnet Portfolio Solutions’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Buy
2,692
+72
+3% +$30.4K 0.01% 690
2026
Q1
$1.24M Sell
2,620
-2,614
-50% -$1.32M 0.01% 571
2025
Q4
$2.44M Sell
5,234
-5,507
-51% -$2.56M 0.01% 504
2025
Q3
$4.58M Sell
10,741
-1,702
-14% -$660K 0.02% 367
2025
Q2
$4.77M Sell
12,443
-1,837
-13% -$662K 0.02% 375
2025
Q1
$4.93M Sell
14,280
-1,343
-9% -$432K 0.02% 368
2024
Q4
$4.69M Buy
15,623
+2,002
+15% +$700K 0.02% 410
2024
Q3
$5.54M Sell
13,621
-310
-2% -$113K 0.02% 365
2024
Q2
$4.48M Sell
13,931
-1,619
-10% -$526K 0.02% 394
2024
Q1
$5.19M Buy
15,550
+2,276
+17% +$696K 0.02% 365
2023
Q4
$3.59M Buy
13,274
+10,352
+354% +$2.56M 0.01% 421
2023
Q3
$719K Buy
+2,922
New +$800K ﹤0.01% 845

Other funds holding HCA

Envestnet Portfolio Solutions's HCA Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its HCA Healthcare (HCA) stake by 2.7% in Q2 2026, buying an estimated $30.4K and bringing the position to 2,692 shares worth $1.05M. The position accounts for 0.01% of the portfolio, ranked #690.

Envestnet Portfolio Solutions first reported a position in HCA in Q3 2023 and has held it in 12 quarters since. The position peaked at $5.54M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Envestnet Portfolio Solutions held 2,692 shares of HCA Healthcare worth $1.05M as of Q2 2026.
  • Envestnet Portfolio Solutions bought 72 HCA Healthcare shares in Q2 2026, an estimated $30.4K.
  • HCA Healthcare made up 0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #690 holding.
  • Envestnet Portfolio Solutions first reported a position in HCA Healthcare in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's HCA Healthcare position peaked at $5.54M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.